160 related articles for article (PubMed ID: 20939765)
1. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Liu Y; She M; Wu Z; Dai R
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
[TBL] [Abstract][Full Text] [Related]
2. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
3. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.
Sridar C; Goosen TC; Kent UM; Williams JA; Hollenberg PF
Drug Metab Dispos; 2004 Jun; 32(6):587-94. PubMed ID: 15155549
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
[TBL] [Abstract][Full Text] [Related]
5. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
7. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
8. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
9. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
10. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
11. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms.
Teng Y; Nian H; Zhao H; Chen P; Wang G
Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
Kerdpin O; Knights KM; Elliot DJ; Miners JO
Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
[TBL] [Abstract][Full Text] [Related]
15. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
[TBL] [Abstract][Full Text] [Related]
16. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver.
Huang T; Fang ZZ; Zhang YY; Zhu LL; Feng LL; Zheng W; Cao YF; Sun DX; Yang L
Pharmazie; 2011 Mar; 66(3):212-5. PubMed ID: 21553653
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
19. Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.
Dong DG; Zhang Y; Zhang SL; Lv J; Guo EM; Fang ZZ; Cao YF
Pharmazie; 2014 Jan; 69(1):60-3. PubMed ID: 24601226
[TBL] [Abstract][Full Text] [Related]
20. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
